Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2018 Earnings

3MayConfirmed

Q3 2017

Q4 2017

Q1 2018

Q2 2018

-5.33

-4.77

-4.21

-3.66

Details

Expected EPS

-5.325317

Actual EPS

-4.972646999999999

Surprise EPS

0.35

Surprise Percent

+6.62%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.972646999999999 per share for Q2 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.